Processa Pharmaceuticals Earnings Preview
Processa Pharmaceuticals (NASDAQ:PCSA) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement.
Analysts estimate that Processa Pharmaceuticals will report an earnings per share (EPS) of $-0.19.
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell
• NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
Processa Pharma Reports Was Cleared By FDA To Proceed With Phase 2a Trial For Treatment Of Gastroparesis
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for
Processa Pharmaceuticals Shares Spike Higher; Hearing TippingPointStocks Raises Price Target From $50 To $55
https://tippingpointstocks.com/login/?mepr-unauth-page=10824&redirect_to=%2Ftps-research-report-pcsa%2F
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
FREYR Battery, Globus Maritime, Processa Pharma Shares Move Higher Following TipRanks Tweet Highlighting Article ‘Buy These 3 Stocks Before They Double (or More), Say Analysts’
https://www.tipranks.com/news/article/buy-these-3-stocks-before-they-double-or-more-say-analysts/
Oppenheimer Initiates Coverage On Processa Pharmaceuticals with Outperform Rating, Announces Price Target of $20
Oppenheimer analyst Francois Brisebois initiates coverage on Processa Pharmaceuticals (NASDAQ:PCSA) with a Outperform rating and announces Price Target of $20.
Oppenheimer Initiates Coverage On Processa Pharmaceuticals with Outperform Rating, Announces Price Target of $20
Oppenheimer analyst Francois Brisebois initiates coverage on Processa Pharmaceuticals (NASDAQ:PCSA) with a Outperform rating and announces Price Target of $20.
45 Biggest Movers From Yesterday
Gainers
Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.